Back to News
Market Impact: 0.4

UBS Reiterates Informa plc

UBSSPWOPNCNDAQ
Analyst InsightsAnalyst EstimatesCompany FundamentalsCorporate EarningsCorporate Guidance & OutlookInvestor Sentiment & Positioning
UBS Reiterates Informa plc

UBS reiterated a Buy recommendation for Informa plc (OTCPK:IFJPY) on November 7, 2025, establishing an average one-year price target of $28.66, which suggests a 38.71% upside from its latest closing price of $20.66. This positive analyst outlook comes despite projected annual revenue decreasing by 23.36% to $2,984MM and a non-GAAP EPS forecast of $0.45. Institutional sentiment appears mixed, with a 16.67% reduction in the number of funds holding IFJPY and a 28.87% decrease in total shares owned, although the average portfolio weight dedicated to the stock increased by 17.69%.

Analysis

UBS reiterated a Buy recommendation for Informa plc (OTCPK:IFJPY) on November 7, 2025, setting an average one-year price target of $28.66. This target suggests a substantial 38.71% upside from the latest reported closing price of $20.66, with analyst forecasts ranging from $25.91 to $34.02, indicating a strong positive outlook from the firm. However, this bullish analyst sentiment is juxtaposed against a projected annual revenue decrease of 23.36% to $2,984MM, alongside a projected non-GAAP EPS of $0.45. This divergence between a strong price target and declining top-line forecasts warrants closer examination into the underlying drivers of the analyst's valuation. Institutional investor sentiment for IFJPY appears mixed; while the number of funds reporting positions decreased by 16.67% (1 owner) and total shares owned by institutions declined by 28.87% to 23K shares, the average portfolio weight dedicated to IFJPY by these funds increased by 17.69%. This suggests that while fewer institutions hold the stock, those that do are allocating a larger proportion of their portfolios to it, with Fiduciary Management notably increasing its allocation by 22.22% and shares by 13.40%, contrasting with Rhumbline Advisers' 19.70% decrease in allocation and 31.67% reduction in shares.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo